Cargando…
Active Immunization Against the Vascular Endothelial Growth Factor Receptor flk1 Inhibits Tumor Angiogenesis and Metastasis
The vascular endothelial growth factor (VEGF) receptor fetal liver kinase 1 (flk1; VEGFR-2, KDR) is an endothelial cell–specific receptor tyrosine kinase that mediates physiological and pathological angiogenesis. We hypothesized that an active immunotherapy approach targeting flk1 may inhibit tumor...
Autores principales: | Li, Yiwen, Wang, Mei-Nai, Li, Hongli, King, Karen D., Bassi, Rajiv, Sun, Haijun, Santiago, Angel, Hooper, Andrea T., Bohlen, Peter, Hicklin, Daniel J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193561/ https://www.ncbi.nlm.nih.gov/pubmed/12070285 http://dx.doi.org/10.1084/jem.20020072 |
Ejemplares similares
-
Impaired tumor growth and angiogenesis in mice heterozygous for Vegfr2 (Flk1)
por: Oladipupo, Sunday S., et al.
Publicado: (2018) -
Fluorescence and Bioluminescence Imaging of Angiogenesis in Flk1-Nano-lantern Transgenic Mice
por: Matsushita, Jun, et al.
Publicado: (2017) -
Therapeutic angiogenesis by transplantation of induced pluripotent stem cell-derived Flk-1 positive cells
por: Suzuki, Hirohiko, et al.
Publicado: (2010) -
Src Kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells
por: Chou, Mary T, et al.
Publicado: (2002) -
VEGF/Flk1 Mechanism is Involved in Roxarsone Promotion of Rat Endothelial Cell Growth and B16F10 Xenograft Tumor Angiogenesis
por: Chen, Shihao, et al.
Publicado: (2019)